Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health Corporation (CVS) has announced early results of its cash tender offers for up to $6 billion in senior notes due in 2023 and 2025. The offers include 4% and 3.7% senior notes due 2023, and 4.1% and 3.875% senior notes due 2025. As of the early tender date on August 25, 2020, significant amounts have been tendered, with notable participation exceeding the maximum amounts set for each note series. CVS plans to accept valid tenders on a prorated basis due to high demand, with settlement expected on August 27, 2020. The total consideration includes an early tender payment of $30 per $1,000.
Summary not available.
CVS Health emphasizes the importance of vaccinations amid COVID-19, urging the public to get flu shots this season. A survey revealed that 66% of U.S. consumers intend to receive a flu shot, up from 34% in January 2020, with many opting for earlier immunizations. Flu shots are available at nearly 10,000 CVS Pharmacy and 100 MinuteClinic locations across the U.S. To ensure safety, CVS has implemented health protocols during vaccination. Customers can receive a $5 coupon for a $20 purchase when they get a flu shot, valid until October 31.
CVS Health is expanding its COVID-19 testing capacity by launching 77 additional drive-thru test sites in Florida, bringing the total to 298 locations in the state effective August 21, 2020. This initiative is part of CVS's broader effort to enhance access to testing, with over 1,900 testing locations nationwide since May. Patients will have no out-of-pocket costs as tests are covered by insurance or funded through a program for the uninsured. CVS aims to provide test results within 2-5 days, improving turnaround times through partnerships with independent labs.
Aetna, part of CVS Health, is launching the Attain Games, a virtual wellness event from August 23 to August 29, 2020. The event features daily challenges tailored by U.S. athletes, including workouts and mindfulness activities, encouraging users to achieve health goals at home. Participants earn points, vying for gold, silver, and bronze statuses. Since its 2019 launch, the Attain app has seen users burn 6 billion calories and redeem $1.8 million in rewards. The program emphasizes user privacy, offering voluntary participation with secure data handling.
CVS Health announced the hiring of approximately 300 new jobs in Arizona as part of its response to the expected surge in demand for influenza vaccinations and ongoing COVID-19 testing. These seasonal roles, including part-time and full-time licensed pharmacy technicians, aim to strengthen healthcare access in underserved areas. The initiative comes amid high unemployment rates due to the pandemic. Candidates must have a technician in training license. This expansion highlights CVS's commitment to public health and job creation in the state.
CVS Health Corporation (NYSE: CVS) has launched cash tender offers totaling $6 billion for its Senior Notes due in 2023 and 2025. The offers aim to refinance existing debt with up to $3 billion available for each group of notes. Key dates include the Early Tender Date on August 25, 2020, and the Expiration Date on September 9, 2020. These strategic moves are designed to lower CVS Health's overall indebtedness and enhance financial flexibility.
CVS Health has launched a free rapid COVID-19 testing site in Glendale, Arizona, effective August 7, 2020. The site, located at 6030 North 43rd Ave., aims to enhance community access to testing, particularly in underserved areas. Testing is available by appointment, requiring pre-registration. Results will be provided on-the-spot, and no personal vehicle is needed. CVS collaborates with local organizations, including Valle del Sol and Mercy Care, to facilitate awareness and support for those tested. The initiative reflects CVS's commitment to addressing health disparities and expanding testing across the country.
CVS Health reports a 3.0% increase in total revenues for Q2 2020, reaching $65.3 billion, and a 40.5% rise in GAAP operating income to $4.7 billion. Adjusted EPS rose to $2.64, reflecting a strong response to COVID-19. The company raised its full-year GAAP diluted EPS guidance to $5.59-$5.72 and adjusted EPS to $7.14-$7.27. Significant operational efforts include over 1,800 COVID-19 test sites and the launch of Return Ready, a testing solution for businesses. Despite challenges in Retail due to pandemic-related restrictions, overall performance remained solid.
CVS Health's Aetna has launched a new initiative to tackle the maternal health crisis in the U.S., specifically targeting the prevention of preeclampsia, a condition causing significant maternal and infant mortality. This first-of-its-kind program identifies at-risk pregnant women through data analytics, providing them with personalized care kits containing low-dose aspirin and educational materials. The initiative aims to enhance prenatal care access, especially amid challenges posed by the COVID-19 pandemic, addressing alarming trends in maternal health disparities.